Alcyomics Revenue
Biotechnology Research • 
Newcastle upon Tyne, England, United Kingdom • 11-20 Employees
Alcyomics revenue & valuation
| Annual revenue | $6,000,000 |
| Revenue per employee | $500,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $19,200,000 |
| Total funding | $370,600 |
Key Contact at Alcyomics
Anne Dickinson
Chief Executive Officer
Company overview
| Headquarters | Bulman House, Regent Centre , Gosforth, Newcastle upon Tyne, NE3 3LS, GB |
| Phone number | +446102853 |
| Website | |
| NAICS | 541714 |
| SIC | 873 |
| Keywords | Cosmetics, 3D Models, Assay Development, Neurotoxicity, Cell Line Development, Ipsc, Immunotoxicity, Atopic Dermatitis, Cellular Therapies, Allergenicity & Efficacy Testing Of Drugs, Immunogenicity Testing Of Monoclonal Antibodies, Safety Assessment Of Cosmeceuticals, Stratified/Personalised Medicine, Preclinical Testing As First-In-Man Studies, Disease Modeling, In Vitro Immuno Toxicology, Monoclonal Antibody Safety, Oecd Testing |
| Founded | 2007 |
| Employees | 11-20 |
| Socials |
Alcyomics Email Formats
Alcyomics uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@alcyomics.com), used 69.2% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@alcyomics.com | 69.2% |
{first initial}.{last name} | j.doe@alcyomics.com | 30.8% |
About Alcyomics
Alcyomics is a specialist clinical research organization (CRO) supporting the pharmaceutical, biotechnology, and cosmetics industries. We offer full assay services and technical consultancy in immuno-toxicology. This is underpinned by our patented human in vitro skin assay platform, Skimune®, which provides highly sensitive detection of adverse immune reactions for pre-clinical testing of small and large molecule drugs, monoclonal antibodies, cellular therapies, cosmetic compounds etc. plus many more. Further to our immunotoxicity platforms we also specialise in 3D assay design, optimisation and validation. We have a number of 3D assays in-house such as; - Autologous skin model, Skimune 3D, for high-throughput immunotoxicity testing. - 3D innervated skin model is based in a 96-well scaffold system and has been specifically validated to detect peripheral toxicity against monoclonal antibodies and chemical insults. - Bioprinted osteo-chondral model incorporates the complex environment present in osteoarthritis. - Autologous atopic dermatitis models incorporating immune cellular function to assess compound function, efficacy and toxicity. From our state of the art facilities based within the custom built Biosphere labs in Newcastle-upon-Tyne, UK, we provide assured, experienced, professional assay support and consultancy to local, national, and international clients. Our Mission at Alcyomics is to provide robust in vitro human assays to the pharmaceutical, biotechnology, chemical and cosmetic industries that enable early detection of adverse immune reactions, reducing risk and cost in the development of drugs and compounds. www.alcyomics.com
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
Alcyomics has 5 employees across 3 departments.
Departments
Number of employees
Alcyomics Tech Stack
Discover the technologies and tools that power Alcyomics's digital infrastructure, from frameworks to analytics platforms.
Hosting
JavaScript libraries
Tag managers
UI frameworks
JavaScript libraries
Programming languages
Reverse proxies
Miscellaneous
Page builders
Blogs
UI frameworks
Analytics
France
Morocco
United States
Frequently asked questions
4.8
40,000 users
